Can Luvox (fluvoxamine) cause hair loss in a patient with a history of hair loss while taking Celexa (citalopram) and Cymbalta (duloxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Luvox (Fluvoxamine) Cause Hair Loss?

Yes, fluvoxamine can cause hair loss, though it appears to be a rare adverse effect, and given your history of hair loss with citalopram and duloxetine, you may be at increased risk for this side effect with fluvoxamine as well. 1

Evidence from FDA Drug Label

  • The FDA label for fluvoxamine explicitly lists alopecia as an infrequent adverse event (occurring between 1/100 and 1/1000 patients) under skin-related side effects. 1
  • This official documentation confirms that hair loss is a recognized, though uncommon, side effect of fluvoxamine treatment. 1

Risk Factors Based on Your History

  • Your prior hair loss with citalopram (Celexa) suggests you may have increased susceptibility to SSRI-induced alopecia, as research demonstrates that alopecia risk varies between individuals and appears more common in women. 2
  • Studies show that alopecia associated with SSRIs typically develops 6 weeks after treatment initiation, affecting primarily the frontal scalp area. 3, 4
  • The overall reporting rate for SSRI-induced alopecia ranges from 4.5 to 20.1 reports per million patient-years, with significant variation between different SSRIs. 2

Comparison Between SSRIs

  • Sertraline shows the highest association with hair loss among SSRIs, with statistically significant reporting rates in both Swedish and international adverse drug reaction databases. 2
  • Citalopram (which you previously took) demonstrated a reporting rate of 4.5 per million patient-years and showed significant association with alopecia in international databases. 2
  • Fluvoxamine has less published data on hair loss compared to other SSRIs, but the FDA label confirms it occurs. 1
  • Case reports document hair loss with fluoxetine, paroxetine, and sertraline, with some patients experiencing resolution after switching between SSRIs. 3, 5, 6, 4

Duloxetine (Cymbalta) Context

  • While you mentioned hair loss with duloxetine, the SNRI class guidelines do not list alopecia as a common adverse effect, though individual susceptibility varies. 7
  • Your experience with both an SSRI (citalopram) and SNRI (duloxetine) causing hair loss suggests you may have a predisposition to antidepressant-induced alopecia regardless of medication class. 7

Clinical Monitoring Recommendations

  • Monitor for hair loss starting at 6 weeks after initiating fluvoxamine, as this is the typical onset period for SSRI-induced alopecia. 3, 4
  • Hair loss typically presents as diffuse thinning in the frontal scalp area rather than patchy alopecia. 3, 4
  • If hair loss develops, cessation of the medication typically results in regrowth, as documented in multiple case reports. 3, 5, 4

Alternative Considerations

  • Escitalopram may represent a lower-risk SSRI option if you need to switch, as it has the least effect on cytochrome P450 enzymes and fewer reported adverse effects overall, though hair loss can still occur. 8
  • Consider ruling out other causes of hair loss through laboratory testing (thyroid function, ferritin, vitamin D, zinc levels) before attributing symptoms solely to medication. 7

Important Caveats

  • The risk of hair loss must be weighed against the benefits of treating your underlying psychiatric condition, as untreated anxiety or depression significantly impacts quality of life. 7
  • Hair loss from SSRIs is typically reversible upon discontinuation, unlike some other medication-induced alopecias. 3, 5, 4
  • Never abruptly discontinue fluvoxamine if hair loss develops; taper slowly over 10-14 days to avoid discontinuation syndrome. 8

References

Research

The first male case with fluoxetine induced hair loss and review of the literature.

European review for medical and pharmacological sciences, 2021

Research

Sertraline-associated hair loss.

Journal of drugs in dermatology : JDD, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Escitalopram Side Effects and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.